[1]
Saenz, E.V. et al. 2023. A Comprehensive Analysis of Visfatin Drug in Type 2 Diabetes, Insulin Resistance, and Cardiovascular Disease. Journal of Prevention, Diagnosis and Management of Human Diseases . 3, 04 (Jun. 2023), 9–17. DOI:https://doi.org/10.55529/jpdmhd.34.9.17.